← Back
Data updated: Mar 10, 2026
LEXENPHARM
Respiratory
LEXENPHARM is a generic drug manufacturer focused on Respiratory.
2024
Since
3
Drugs
-
Trials
18
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ALBUTEROL SULFATE 2025-12-01
ALBUTEROL SULFATE 2025-11-21
Labeling
ARFORMOTEROL TARTRATE 2025-04-25
ALBUTEROL SULFATE 2025-03-12
ARFORMOTEROL TARTRATE 2025-03-07
FORMOTEROL FUMARATE 2025-02-11
ARFORMOTEROL TARTRATE 2025-02-03
FORMOTEROL FUMARATE 2025-01-30
ARFORMOTEROL TARTRATE 2024-11-18
FORMOTEROL FUMARATE 2024-10-22
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 100%
2 drugs
Pipeline Strength Pro
Loading...
Discontinued (0)
Company Info
- First Approval
- 2024-05-03
- Latest
- 2024-11-18
- Applications
- 3